IGF1 and neoplasm: For instance, targeting hepatocyte growth factor (HGF)-MET or IGF-1/IGF-1R signaling pathways—both critical for maintaining DTP states mediated through tumor-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs)—has shown promise in preclinical models (Yi et al., 2018).